Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA) -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (1178)	5/19/1999 4:13:00 PM
From: bob zagorin	Read Replies (1) \| Respond to of 1870

some more inf. on the drop. Murphy (CTSL) said in his newsletter mailed after the close friday to take advantage of he runup and exit the stock. This probably started the decline monday morning which then picked up some momentum. of course, none of his subscribers got to sell at friday's price. it's also typical of murphy who i have to admit seems to be losing touch with reality. he strongly recommended this stock when it was 20-30 (split adjusted) then lost faith when it was down around $1 even though he said the Jago joint venture was worth $100m (going by memory). Now that they have positive results from their first clinical trials and good results from phase 1s, he says to "exit". He has explained that his poor results have had a lot to do with his investments in small cap techs and bio and so he's moving toward larger cos. I think he's going to do this just as the market moves the other way. Myself, i'm going to stick with GNTA until we find out whether their lead compounds are as effective as the appear to be.